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Abstract: Much attention has been focused on neural cell transplantation because of its 
promising clinical applications. We have reported that embryonic stem (ES) cell derived 
neural stem/progenitor cell transplantation significantly improved motor functions in a 
hemiplegic mouse model. It is important to understand the molecular mechanisms governing 
neural regeneration of the damaged motor cortex after the transplantation. Recent 
investigations disclosed that chemokines participated in the regulation of migration and 
maturation of neural cell grafts. In this review, we summarize the involvement of 
inflammatory chemokines including stromal cell derived factor 1 (SDF1) in neural 
regeneration after ES cell derived neural stem/progenitor cell transplantation in mouse 
stroke models. 
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1. Introduction  
Cerebral vascular diseases often cause severe neurological dysfunctions with high disability and 
mortality [1]. There is accumulating evidence that supports effectiveness of neural tissue transplantation on 
the recovery of neurological dysfunctions in experimental stroke models [1–6]. In rodents, endogenous 
neural stem cells are enriched in the subventricular zone (SVZ) [7] and the subgranular zone (SGZ) [8] 
even in adult brains. Neural stem cells in the SVZ migrate to the olfactory bulb (OB) through the 
rostral migratory stream (RMS) and they differentiate into neural cells [9]. This migration of stem cells 
is called chain migration because of its histological features. Neural stem/progenitor cells have high 
abilities to proliferate and to differentiate into several neural cell types in the CNS [10–12]. Therefore, 
endogenous neural stem/progenitor cells may be responsible for the spontaneous functional recovery 
frequently observed in the damaged CNS of mice. In brain injury models of mice, astrocytes around 
the injured area activate neural stem cells in SVZ and SGZ, and promote them to migrate to   
the injured area, where they differentiate into mature neural cells (Figure 1) [6,13,14]. However, the 
number of endogenous neural stem/progenitor cells is not sufficient to repair the damaged brain efficiently. 
The neural cells derived from the endogenous neural stem cells migrating from SVZ in the injured area 
occupy only 0.2% of the dead neurons in the middle cerebral artery occlusion (MCAO) model [13]. 
The human brain has RMS that consists of similar cells to the rodent brain including OB [15]. The 
activity of cells in RMS is relatively lower in humans than in rodents. It suggests that the cell 
replacement rate in human OB is much lower than in rodents. Moreover the weight of human OB is 
below 0.1% of the whole human brain, whereas rodent OB occupies more than 20% of the total rodent 
brain [16]. These findings suggest that the regenerative and proliferating potential of the cells in OB 
are much lower in humans than in rodents [15]. 
Transplantation of exogenous neural cells derived from ES and induced pluripotent stem (iPS) cells 
has the possibility to provide sufficient numbers of neural cells to the damaged tissue, leading to the 
restoration of lost motor functions. In our hemiplegic model of mice, transplantation with both mouse 
and monkey ES cell derived neural stem/progenitor cells improved motor functions [4,5,17]. The 
neural graft derived from the ES cells migrated to the injured area and expressed neural cell adhesion 
molecules which mediated homophilic binding [5]. We speculate that both cell-to-cell and cell-to-soluble 
factor interactions are essential for the grafted neural stem/progenitor cells to differentiate toward 
neural cells suitable for their neighboring environment and to form new neural circuits with the 
damaged host neurons. 
Chemokines are small polypeptides consisting of about 100 amino acids, initially identified as 
molecules which belong to a subtype of cytokines produced from immune cells, and contribute to the 
maturation and trafficking of leukocytes. Chemokines and their receptors play an important role in 
neural cell migration and they are constitutively expressed in glial and neural cells in the CNS. 
Chemokines are categorized into four groups (CXC, CC, C and CX3C chemokines) by the number 
and position of the conserved cysteine residues in their amino termini. Chemokine receptors are 
categorized into four groups (CXCRn, CCRn, XCRn and CX3CRn), each corresponding to the 
respective chemokine nomenclature above, and belong to seven-transmembrane-domain G-protein 
coupled receptors. Several chemokines are involved in neural formation in both ontogenic development 
and tissue regeneration through their interaction with neural cell surface molecules [18–20]. Int. J. Mol. Sci. 2012, 13 2638 
 
 
Figure 1. Schematic representation of neural cell migration in mouse brain. (a and b) 
Stereographic drawing of the brain and three dimensional positions of the subventricular 
zone (SVZ), subgranular zone (SGZ), rostral migratory stream (RMS) and olfactory bulb 
(OB). Continuous generation of neural cells is shown in both SVZ of the lateral ventricle 
and SGZ of the dentate gyrus in the mouse hippocampus; (c and d) Endogenous neural 
stem cell (NSC) migration to facilitate regeneration of the damaged area in the middle 
cerebral artery occlusion (MCAO) model. Migratory pathway of the endogenous neural 
cells generated in SVZ is shown. They migrate to the injured area directly or through RMS 
and OB. However, numbers of the endogenous cells are insufficient to enable the repair of 
the damaged tissue; (e and f) Neural cell migration after ES cell derived NSC transplantation 
in the hemiplegic mouse with brain injury. We injected ES cell derived neural stem/progenitor 
cells into the periventricular region of the striatum. The transplanted cells migrated to the 
injured motor cortex and located diffusely over the cortex. We speculated that the grafted 
cells replaced and regenerated the damaged cortex, leading to recovery of the hemiplegia. 
 
In our hemiplegic model, stromal cell derived factor 1 (SDF1) and some neural cell associated 
adhesion molecules, such as L1 cell adhesion molecule (L1CAM), neural cell adhesion molecule 
(NCAM) and N-cadherin, were associated with migration and maturation of the neural stem/progenitor 
cells derived from monkey ES cells. Here, we review chemokine regulation of neural regeneration 
after ES cell derived neural stem/progenitor cell transplantation. Int. J. Mol. Sci. 2012, 13 2639 
 
 
2. Chemokine Expressions in the CNS  
In the human physiological condition, several chemokines such as monocyte chemoattractant 
protein 1 (MCP1), cutaneous T cell-attracting chemokine (CTACK), SDF1 and fractalkine are 
expressed on neural cells and astrocytes of the brain and on primary cells isolated from the CNS (Table 1). 
The expressions of interferon-γ-inducible protein of 10 kDa (IP10), SDF1 and fractalkine are enhanced 
in several human diseases such as HIV infection and multiple sclerosis. Certain chemokines play a key 
role in brain development (Table 2). Regulated upon activation, normal T cell expressed and secreted 
(RANTES) and SDF1 evoke neural cell migration, while Growth-regulated oncogene α (GROα), 
MCP1, Macrophage inflammatory protein 1α (MIP1α), RANTES and SDF1 affect astrocyte proliferation.  
Table 1. Expression of chemokine molecules in human brain cells. 
Chemokine  Receptor Distribution 
Physiological    
In vivo    
MCP1/CCL2  CCR2  Fetal and adult brain: Neurons [21] 
CTACK/CCL27  CCR10  Adult brain: Neurons [22] 
SDF1/CXCL12  CXCR4  Adult brain: Neurons [23] 
Fractalkine/CX3CL1  CX3CR1  Adult brain: Astrocytes [24] 
In vitro    
MCP1/CCL2  CCR2  Primary astrocyte culture [25] 
MIP1α/CCL3  CCR3  Primary astrocyte culture [25] 
MIP1β/CCL4  CCR5  Primary astrocyte culture [25] 
RANTES/CCL5  CCR5  Primary astrocyte culture [25] 
SDF1/CXCL12  CXCR4  Primary fetal neural cell culture [23] 
Fractalkine/CX3CL1  CX3CR1  Primary neural and glial cell culture [26] 
Pathological    
MCP1/CCL2  CCR2  Astrocytes in HIV encephalitis [27] 
RANTES/CCL5  CCR5  Astrocytes in HIV encephalitis [27] 
IP10/CXCL10  CXCR3  Neurons in HIV encephalitis [28] 
SDF1/CXCL12  CXCR4  Neurons and Astrocytes in AIDS dementia [23] 
Fractalkine/CX3CL1 CX3CR1 
Astrocytes in multiple sclerosis [24] 
Neurons in HIV encephalitis [29] 
MCP1: monocyte chemoattractant protein 1; CTACK: cutaneous T cell-attracting chemokine; SDF1: stromal 
cell derived factor 1; MIP1: Macrophage inflammatory protein 1; RANTES: regulated upon activation, normal 
T cell expressed and secreted; IP10: interferon-γ-inducible protein of 10 kDa. 
Table 2. Chemokine expression in brain development. 
Chemokine  Receptor Target  Cells 
Cell Migration    
RANTES/CCL5 CCR5  Neurons  [30] 
SDF1/CXCL12  CXCR4  Cerebellar granule neurons [31] 
    Cortical neural progenitors [32] 
    Dentate gyrus granular neurons [33] Int. J. Mol. Sci. 2012, 13 2640 
 
 
Table 2. Cont. 
Cell Proliferation    
MCP1/CCL2  CCR2 Astrocytes  [34]   
MIP1α/CCL3 CCR3  Astrocytes  [34] 
RANTES/CCL5 CCR5  Astrocytes  [25] 
GROα/CXCL1  CXCR2  Astrocytes, Oligodendrocyte precursors [35] 
SDF1/CXCL12 CXCR4  Astrocytes  [36,37] 
Upregulations of GROα [38], MCP1 [39], MIP1α [40] and SDF1 [41,42] are shown in the 
hemiplegic models (Figure 2) [5,41,42], and in patients with cerebral vascular diseases. These 
chemokines are suggested to have neuroprotective functions [42–44]. Thus, the same chemokine 
induces both CNS inflammation and regeneration. Judging from the poor clinical outcomes with stroke 
patients, the regenerative ability of the chemokine is much less than the inflammation-inducing 
destructive ability in humans. 
Figure 2. Stromal cell derived factor 1 (SDF1) expression by glial fibrillary acidic protein 
(GFAP) positive cells in the damaged motor cortex of mice. Motor cortex was injured and 
stained with anti-SDF1 antibody (Red) and anti-mouse GFAP antibody (Green) in our 
hemiplegic model. Almost all GFAP positive cells expressed SDF1. 




3. Transplanted Neural Cells and Chemokines 
After brain injury, astrocytes respond to some signals from the injured area and produce various 
molecules which provoke neural stem/progenitor cell proliferation, migration and differentiation to 
start regeneration of the damaged tissue (Figure 3a,b) [42–44]. Astrocytes produce several 
inflammatory chemokines, such as SDF1, MCP1, MIP1α, MIP1β, RANTES and fractalkine [18,20]. 
Neural stem/progenitor cells express chemokine receptors, such as CCR2, CCR5, CXCR3, and 
CXCR4 [45]. It has been reported that CCR2 (the receptor of MCP1) and CXCR4 (the receptor of Int. J. Mol. Sci. 2012, 13 2641 
 
 
SDF1) are involved in the migration of endogenous neural stem cells to the injured area in mice [44,46]. 
Interaction between SDF1 and CXCR4 activates several signaling molecules in neural stem cells 
including p38MAPK, ribosomal S6 kinase, c-Jun and paxillin. The interactions are followed by 
various cell activities, such as proliferation, chemotaxis and migration with conformational changes of 
cytoskeleton for neurite outgrowth. The SDF1/CXCR4 interaction on the neural cell graft activates several 
signaling pathways including mitogen-activated protein kinase (MAPK). Various cellular responses 
including proliferation and migration of the neural cell graft are induced by the MAPK activation. As for 
migration, activated p38MAPK is involved in actin reorganization essential for cell migration. The 
ribosomal S6 kinase (RS6K), which is activated by extracellular signal-regulated kinases (ERK), provokes 
the phosphorylation of cytoskeletal molecules which are mandatory for cell migration and neurite 
elongation. MAP/MEK kinase 1 (MEKK1) is essential for cell migration, because the c-Jun N-terminal 
kinase (JNK), which is phosphorylated by MEKK1, phosphorylates the focal adhesion adaptor molecule, 
paxillin, important for cell migration. Collectively, accumulation of the phosphorylation and subsequent 
activation events following SDF1/CXCR4 interaction brings about neural cell migration, observed in mice 
with neural cell grafts (Figure 3c) [47–50]. SDF1 stimulates cortical astrocyte proliferation through   
Src-ERK1/2 activation [36]. 
SDF1 and CXCR4 are highly expressed in the embryonic brain. Mice with congenital deficit of 
CXCR4 or SDF1 shared the same pathological development, hypoplasia of hippocampal external 
granule cell layer [51,52]. Recent analysis using CXCR4 transfected neural progenitor cells revealed 
that SDF1/CXCR4 regulated adult neural progenitor cell motility but not differentiation [53]. SDF1 
utilizes both CXCR4 and CXCR7 for its receptor. SDF1 activates Galpha (i1) protein-dependent signaling 
pathway through CXCR4. Through CXCR7, SDF1 does not activate Galpha (i1) signaling pathway 
but activates the MAP kinase pathway [54]. In mouse development, CXCR7 also contributes to 
cortical interneuron migration. Mice deficient either in CXCR4 or CXCR7 show similar phenotypes. 
However, there is a distinct difference in the interneuron tangential and radial migration motility 
between CXCR4 and CXCR7 deficient mice during the early embryonic stage [55]. We think that 
further studies are needed to clarify the relation between these molecules in the regeneration of 
damaged CNS after transplantation. 
When we conducted monkey ES cell derived neural cell transplantation into hemiplegic mice with 
brain injury (Figure 1), a significant recovery of motor functions was observed [3]. We found 
unidirectional migration of the neural cells from the grafted periventricular region toward the damaged 
motor cortex where SDF1 was expressed extensively. This migration resembled so-called chain 
migration, physiologically shown in embryonic brain development and adult forebrain (Figure 3b,e). 
Using a microchemotaxis assay in vitro, we showed that the migration ability of mouse and monkey 
ES cell derived neural stem/progenitor cells depended on the concentration gradient of SDF1. It has 
been shown that by the blocking of CXCR4 signaling by AMD3100 in vitro and in vivo, an antagonist 
of CXCR4 [5,56], inhibited migration of the neural stem/progenitor cells. Migration of the neural 
stem/progenitor cells was not affected by other chemokines, such as MCP1, CTACK, RANTES, 
fractalkine and MIP1α. The ES cell derived neural stem/progenitor cells expressed CXCR4 but did not 
express CCR2 or any other major chemokine receptors [5]. Int. J. Mol. Sci. 2012, 13 2642 
 
 
Figure 3. Involvement of chemokines/chemokine receptors in the neural regeneration in an 
experimental hemiplegic model with neural cell transplantation. (a,b) Astrocytes and 
vascular endothelial cells in the injured area (pink colored) produce several chemokines 
(e.g., SDF1). After expressing chemokine receptors (e.g., CXCR4), the neural 
stem/progenitor cells react with the chemokines and then start to move along with the 
concentration gradient of the chemokines, whose concentration is the highest at the injured 
area; (c) The SDF1/CXCR4 interaction on the neural cell graft activates several signaling 
molecules including p38MAPK, ribosomal S6 kinase, c-Jun and paxillin. The interactions 
are followed by various cell activities, such as proliferation, chemotaxis and migration with 
conformational changes of cytoskeleton for neurite outgrowth; (d) Conceptional 
classification of neural cell migration in mice with transplantation. One is multidirectional 
migration and the other is unidirectional migration of neural stem/progenitor cells. 
Multidirectional migration means that neural stem/progenitor cells accumulated in a region 
migrate in all directions; (e) Unidirectional migration means that neural stem/progenitor cells 
continuously move on in one direction, dependent on the lower to higher concentration 
gradient of the chemokines. Cells in the unidirectional migration look like a chain of cells 
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In another in vitro study of our own, we found that ES cells differentiated efficiently into neural 
cells in the presence of SDF1, whereas MCP1 and other major chemokines did not affect their 
differentiation. We think that migration and subsequent maturation of the neural stem/progenitor cells 
transplanted to the damaged brain are mainly caused by SDF1 secreted from glial cells accumulating 
around the injured area (Figures 2 and 3b) [5]. 
We found that ES cell derived neural stem/progenitor cells migrated as a cell aggregate from the 
periventricular region of the striatum where they had been injected in the damaged motor cortex. The 
migration was inhibited by the administration of AMD3100, suggesting that the cells were guided by 
the concentration gradient of SDF1 which was secreted by glial cells accumulated in the damaged 
cortex. Migration of the grafted neural stem/progenitor cells resembled so-called chain migration, but 
not radial (multidirectional) migration in the recipient brain (Figure 3d) [5]. 
CCR2 deficient mice do not show any abnormality of neural stem/progenitor cells throughout the 
embryonic CNS development. Low expressions of MCP1 and CCR2 molecules on the CNS are Int. J. Mol. Sci. 2012, 13 2644 
 
 
physiologically recognized in the mice throughout their lives. Redundancy of chemokines/cytokines 
may explain the lack of abnormality [20]. 
4. Neural Stem/Progenitor Cells and Neural Cell Associated Adhesion Molecules 
Eventually, the grafted cells migrate into the superficial layer of the injured motor cortex and re-connect 
the pyramidal tract which has once been damaged with their extended axons. Migration of the 
endogenous neural cells in the adult forebrain, including RMS, needs interactions with neighboring 
cells via neural cell associated adhesion molecules and other cell surface molecules. 
The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is one of the 
homophilic binding cell adhesion molecules. Homophilic PSA-NCAM interaction between 
endogenous neural stem/progenitor cells emerging from SVZ and surrounding neural cells, which have 
been existing there, is important to form the chain migration (or tangentinal migration) of RMS [57,58]. 
The neural cells in chain migration are surrounded by a microenvironment mainly consisting of 
astrocytes, with which the neural stem/progenitor cells interact to promote their migration (Figure 3b) [59]. 
Neural cell associated adhesion molecules, such as L1CAM and NCAM, and N-cadherin are 
important for axon elongation [60,61]. L1CAM and NCAM are members of the immunoglobulin 
superfamily and they are widely expressed in neural tissues during development. Both L1CAM and 
NCAM mediate homophilic and heterophilic adhesion [62]. Cell adhesion molecules are assigned an 
important role in the cytoskeletal and transcriptional event during neurite outgrowth [60]. L1CAM 
plays a role in neurite extension and NCAM is important for the cone protrusive growth of axon [63]. 
L1CAM deficient mice have enlarged ventricles and severe hypoplasia of the corticospinal tract [64]. 
NCAM deficient mice show a primary defect in embryonic neural cell migration and subsequent 
defects in axon growth and fasciculation [65]. Mice deficient in N-cadherin show that neuroepithelial 
and radial glial cells do not expand their processes to span the distance and therefore terminate them in 
the middle zone of the cortex, suggesting that N-cadherin contributes to neurite outgrowth and synaptic 
connection [66]. 
In our study, ES cell derived neural stem/progenitor cells started to express NCAM and L1CAM 
mRNAs 4 h after SDF1 stimulation in vitro [5]. The cells grafted to mouse brain started to express 
NCAM, L1CAM and N-cadherin simultaneously soon after transplantation, and formed homophilic 
and heterophilic intercellular bindings and de novo neural network at the damaged cortex 28 days  
after transplantation [5]. It was possible that L1CAM, NCAM, and N-cadherin induced by SDF1 
contributed to regenerating neural network by promoting the extension of axons/neurites in the 
damaged cortex [67,68]. 
5. Conclusions 
SDF1 and several neural cell adhesion molecules play a role in migration and differentiation of the 
grafted neural stem/progenitor cells and subsequent neural network reconstruction in the damaged 
brain. We found that SDF1 was one of the most important molecules among other chemokines tested 
so far for the regulation of the neural stem/progenitor cell migration and the formation of neural 
network. Endogenous glial cells around the injured area mainly secreted SDF1. NCAM was expressed 
on the transplanted neural cell after reaching the damaged cortex. SDF1 induced to express neural cell Int. J. Mol. Sci. 2012, 13 2645 
 
 
associated adhesion molecules, which in turn helped promote appropriate differentiation of neural 
stem/progenitor cells and subsequent regeneration of neural network in vivo. 
Our hemiplegic mouse model served as a basis to understand the molecular mechanisms governing 
neural regeneration after transplantation, and indicated the importance of SDF1 and the neural 
adhesion molecules for the recovery of motor functions. 
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